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Challenging epidural analgesia as the preferred route for postoperative
analgesia in liver surgery
Good post-operative pain control is a central part of recovery after surgery. ERAS programmes, in particular,
have heavily promoted the use of epidural analgesia for abdominal surgery. This probably owes something to the
roots of ERAS in colorectal surgery however many of the studies on which these recommendations were made
are outdated and relate to very different operative procedures. Epidural analgesia is known to offer good
dynamic and static pain control but does have drawbacks in terms of hypotension, immobility and rare but life
threatening complications of epidural abscess or epidural haematoma. The liver surgery group in Basingstoke
have been one of the major centres pioneering local anaesthetic wound catheter infiltration of upper abdominal
wounds combined with patient controlled opiates as an alternative to epidural analgesia. In this edition of HPB,
Wong-Lu-Hing and colleagues report the Basingstoke experience of wound catheter analgesia after liver resec-
tion in a retrospective comparative cohort analysis including a small group of contemporaneous patients
receiving epidural analgesia (analgesic selection based on surgeon preference). Although not a randomized trial
they clearly show some important benefits from wound catheter analgesia. These were equivalency of analgesia
combined with reduced overall complication rates, reduced opiate requirement and a shorter length of stay
compared with patients receiving epidural analgesia. Further refinements to local anaesthetic protocols such as
additional transversus abdominis plane blocks may improve the effectiveness of this analgesic approach and it
seems certain that this will remain an effective alternative if not a preferred alternative to epidural analgesia in
liver surgery.
Stephen J Wigmore
Safe sensible restraint in gallbladder cancer surgery
Is resection of the extrahepatic bile duct (EBD) a necessary and beneficial component of gallbladder cancer
(GBC) operations? The fear of leaving micro-metastatic disease in the submucosal lymphatics of the EBDwould
be warranted if its resection conferred true oncological and survival benefit. It does not, however. Further, it is
not necessary for an adequate staging lymphadenectomy. Other than increased risk, morbidity and mortality,
routine EBD resection adds nothing in non-jaundiced patients with no gross EBD disease. Wiggers et al. now
provide data that support routinely omitting EBD resection in such patients. Of 58 patients over 12 years who
underwent laparotomy with curative intent for GBC at the AmsterdamMedical Centre, 26 (45%) underwent R0
resection without EBD resection. Three year survival rate was 78%. Seven patients developed recurrent disease
at a median of 9 months. Two patients with distant metastases also had local EBD recurrences, but no patient
developed isolated recurrence at the preserved EBD. Skeptics can point to this study’s retrospective design, its
low patient numbers and its lack of a control EBD resection group, but the results still stand. Routine EBD
resection confers no additional value for R0 GBC resections with negative cystic duct margins and uninvolved
EBD.What does this mean for patients? They can avoid additional risk and morbidity at no oncologic penalty.
They will still face an uncertain future given the aggressive biology of gallbladder cancer.
Mark Callery
Utility of day zero serum amylase following pancreaticoduodenectomy
Lavanniya et al. present a well conducted study which describes the utility of measuring the serum total amylase
on the day of surgery (>4 hours after pancreatic anastomosis). It was hypothesised that elevated serum total
amylase would help predict the subsequent development of a clinically significant pancreatic fistula thereby
allowing early drain removal for those deemed to be low risk for clinically significant POPF. The methodology
used a test cohort to determine the optimal cut-off value for the serum total amylase and then a larger validation
cohort to confirm its utility. The authors identified an optimal serum total amylase value of 130 IU/l to predict
clinically significant POPF.Although thepositive predictive valuewas lowat 36% thenegative predictive valuewas
high at 88%.This utility remainedwhen analysing subgroups at high risk of POPF.Multivariate analysis identified
only day zero serum total amylase >130 IU/l and soft pancreatic parenchyma as independent factors associated
with clinically relevant POPF leading the authors to conclude that this test can be a useful tool in the decision
making for early drain removal. Interestingly, all patients received somatostatin analogues and the median blood
loss was high (1450mls), both of which have been shown to be associated with increased incidence of POPF. The
method used to transect the pancreas was variable and not obviously analysed as a risk factor. However, these
findings raise a separate and very important question. What happens to the pancreatic parenchyma at the
transection margin in the early post operative period? There are no specific data on this but clues can be gleaned
from clinical experience and other areas of surgery. Is it possible that transient tissue hypoxia occurs leads to
necrotising pancreatitis and subsequent anastomotic breakdown. If correct, the answer in preventing POPFmay
not be technical but in preventing local tissue hypoxia.
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